{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:01:52Z","timestamp":1777366912912,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s12098-026-06121-z","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T05:46:29Z","timestamp":1775540789000},"page":"522-528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypertension: Evaluation and Management"],"prefix":"10.1007","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3509-5404","authenticated-orcid":false,"given":"Kirtisudha","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"6121_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441\u201350.","journal-title":"Circulation"},{"key":"6121_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40885-020-00156-w","volume":"26","author":"M Ashraf","year":"2020","unstructured":"Ashraf M, Irshad M, Parry NA. Pediatric hypertension: an updated review. Clin Hypertens. 2020;26:22.","journal-title":"Clin Hypertens"},{"key":"6121_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1001\/jamapediatrics.2019.3310","volume":"173","author":"P Song","year":"2019","unstructured":"Song P, Zhang Y, Yu J, et al. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 2019;173:1154\u201363.","journal-title":"JAMA Pediatr"},{"key":"6121_CR4","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, et al; SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904.","journal-title":"Pediatrics"},{"key":"6121_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.118.11673","volume":"73","author":"CS Bell","year":"2019","unstructured":"Bell CS, Samuel JP, Samuels JA. Prevalence of hypertension in children. Hypertension. 2019;73:148\u201352.","journal-title":"Hypertension"},{"key":"6121_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1542\/peds.114.S2.555","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555\u201376.","journal-title":"Pediatrics"},{"key":"6121_CR7","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","volume":"73","author":"P Muntner","year":"2019","unstructured":"Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019;73:e35\u201366.","journal-title":"Hypertension"},{"key":"6121_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jpeds.2011.08.071","volume":"160","author":"JT Flynn","year":"2012","unstructured":"Flynn JT, Pierce CB, Miller ER 3rd, et al; Chronic Kidney Disease in Children Study Group. Reliability of resting blood pressure measurement and classification using an oscillometric device in children with chronic kidney disease. J Pediatr. 2012;160:434\u201340.e1.","journal-title":"J Pediatr"},{"key":"6121_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/jch.12196","volume":"15","author":"SB Eliasdottir","year":"2013","unstructured":"Eliasdottir SB, Steinthorsdottir SD, Indridason OS, Palsson R, Edvardsson VO. Comparison of aneroid and oscillometric blood pressure measurements in children. J Clin Hypertens. 2013;15:776\u201383.","journal-title":"J Clin Hypertens"},{"key":"6121_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/HJH.0000000000001178","volume":"35","author":"SL Duncombe","year":"2017","unstructured":"Duncombe SL, Voss C, Harris KC. Oscillometric and auscultatory blood pressure measurement methods in children: a systematic review and meta-analysis. J Hypertens. 2017;35:213\u201324.","journal-title":"J Hypertens"},{"key":"6121_CR11","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, et al. 2023 ESH guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"6121_CR12","first-page":"596","volume":"36","author":"DM Rabi","year":"2020","unstructured":"Rabi DM, McBrien KA, Sapir-Pichhadze R, et al. Hypertension Canada\u2019s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020;36:596\u2013624.","journal-title":"Can J Cardiol"},{"key":"6121_CR13","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. kidney Int. 2024;105:S117\u2013314.","journal-title":"kidney Int"},{"key":"6121_CR14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1053\/j.ajkd.2015.01.008","volume":"65","author":"BA Warady","year":"2015","unstructured":"Warady BA, Abraham AG, Schwartz GJ, et al. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: The Chronic Kidney Disease in Children (CKiD) cohort. Am J Kidney Dis. 2015;65:878\u201388.","journal-title":"Am J Kidney Dis"},{"key":"6121_CR15","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1017\/S136898002400048X","volume":"27","author":"P Loizou","year":"2024","unstructured":"Loizou P, Taylor CM, Buckland G. The dietary approaches to stop hypertension (DASH) dietary pattern in childhood in relation to cardiometabolic risk in adolescence and early adulthood in the ALSPAC birth cohort. Public Health Nutr. 2024;27:e86.","journal-title":"Public Health Nutr"},{"key":"6121_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ekir.2022.02.018","volume":"7","author":"CH Robinson","year":"2022","unstructured":"Robinson CH, Chanchlani R. High blood pressure in children and adolescents: current perspectives and strategies to improve future kidney and cardiovascular health. Kidney Int Rep. 2022;7:954\u201370.","journal-title":"Kidney Int Rep"},{"key":"6121_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1542\/peds.2014-1880","volume":"135","author":"K Resnicow","year":"2015","unstructured":"Resnicow K, McMaster F, Bocian A, et al. Motivational interviewing and dietary counseling for obesity in primary care: an RCT. Pediatrics. 2015;135:649\u201357.","journal-title":"Pediatrics"},{"key":"6121_CR18","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1177\/009127002401102786","volume":"42","author":"T Wells","year":"2002","unstructured":"Wells T, Frame V, Soffer B, et al; Enalapril Pediatric Hypertension Collaborative Study Group. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension. J Clin Pharmacol. 2002;42:870\u201380.","journal-title":"J Clin Pharmacol"},{"key":"6121_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0895-7061(03)00900-2","volume":"16","author":"B Soffer","year":"2003","unstructured":"Soffer B, Zhang Z, Miller K, Vogt BA, Shahinfar S. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension. Am J Hypertens. 2003;16:795\u2013800.","journal-title":"Am J Hypertens"},{"key":"6121_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/01.HYP.0000138069.68413.f0","volume":"44","author":"JS Li","year":"2004","unstructured":"Li JS, Berezny K, Kilaru R, et al. Is the extrapolated adult dose of fosinopril safe and effective in treating hypertensive children? Hypertension. 2004;44:289\u201393.","journal-title":"Hypertension"},{"key":"6121_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/HYPERTENSIONAHA.108.111054","volume":"52","author":"JT Flynn","year":"2008","unstructured":"Flynn JT, Meyers KE, Neto JP, et al; Pediatric Valsartan Study Group. Efficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years. Hypertension. 2008;52:222\u20138.","journal-title":"Hypertension"},{"key":"6121_CR22","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/HJH.0b013e328336b86b","volume":"28","author":"F Schaefer","year":"2010","unstructured":"Schaefer F, van de Walle J, Zurowska A, et al; Candesartan in Children with Hypertension Investigators. Efficacy, safety and pharmacokinetics of candesartan cilexetil in hypertensive children from 1 to less than 6 years of age. J Hypertens. 2010;28:1083\u201390.","journal-title":"J Hypertens"},{"key":"6121_CR23","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1751-7176.2011.00502.x","volume":"13","author":"KE Meyers","year":"2011","unstructured":"Meyers KE, Lieberman K, Solar-Yohay S, Han G, Shi V. The efficacy and safety of valsartan in obese and nonobese pediatric hypertensive patients. J Clin Hypertens. 2011;13:758\u201366.","journal-title":"J Clin Hypertens"},{"key":"6121_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/HYPERTENSIONAHA.109.147702","volume":"55","author":"L Hazan","year":"2010","unstructured":"Hazan L, Hern\u00e1ndez Rodriguez OA, Bhorat AE, Miyazaki K, Tao B, Heyrman R; Assessment of Efficacy and Safety of Olmesartan in Pediatric Hypertension Study Group. A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension. Hypertension. 2010;55:1323\u201330.","journal-title":"Hypertension"},{"key":"6121_CR25","doi-asserted-by":"publisher","first-page":"1042190","DOI":"10.3389\/fcvm.2022.1042190","volume":"9","author":"J Redon","year":"2022","unstructured":"Redon J, Seeman T, Pall D, et al. Narrative update of clinical trials with antihypertensive drugs in children and adolescents. Front Cardiovasc Med. 2022;9:1042190.","journal-title":"Front Cardiovasc Med"},{"key":"6121_CR26","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/0091270006289844","volume":"46","author":"JT Flynn","year":"2006","unstructured":"Flynn JT, Nahata MC, Mahan JD Jr, Portman RJ; PATH-2 Investigators. Population pharmacokinetics of amlodipine in hypertensive children and adolescents. J Clin Pharmacol. 2006;46:905\u201316.","journal-title":"J Clin Pharmacol"},{"key":"6121_CR27","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1007\/s00467-005-1854-4","volume":"20","author":"MP Castaneda","year":"2005","unstructured":"Castaneda MP, Walsh CA, Woroniecki RP, Del Rio M, Flynn JT. Ventricular arrhythmia following short-acting nifedipine administration. Pediatr Nephrol. 2005;20:1000\u20132.","journal-title":"Pediatr Nephrol"},{"key":"6121_CR28","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1751-7176.2010.00347.x","volume":"12","author":"Y Miyashita","year":"2010","unstructured":"Miyashita Y, Peterson D, Rees JM, Flynn JT. Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens. 2010;12:850\u20135.","journal-title":"J Clin Hypertens"},{"key":"6121_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1067\/mpd.2001.114030","volume":"139","author":"JT Flynn","year":"2001","unstructured":"Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE. Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr. 2001;139:38\u201343.","journal-title":"J Pediatr"},{"key":"6121_CR30","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al; FIDELIO-DKD Investigators. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383:2219\u201329.","journal-title":"N Engl J Med"},{"key":"6121_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12098-021-03707-7","volume":"89","author":"S Lad","year":"2022","unstructured":"Lad S, Patil M, Jayashree M, et al. Efficacy and safety of intravenous labetalol in acute hypertensive crisis in children. Indian J Pediatr. 2022;89:7\u201312.","journal-title":"Indian J Pediatr"},{"key":"6121_CR32","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1097\/PCC.0000000000002562","volume":"21","author":"M Wu","year":"2020","unstructured":"Wu M, Ryan KR, Rosenthal DN, Jahadi O, Moss J, Kwiatkowski DM. The use of clevidipine for hypertension in pediatric patients receiving mechanical circulatory support. Pediatr Crit Care Med. 2020;21:e1134\u20139.","journal-title":"Pediatr Crit Care Med"},{"key":"6121_CR33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/HYP.0000000000000007","volume":"63","author":"JT Flynn","year":"2014","unstructured":"Flynn JT, Daniels SR, Hayman LL, et al; American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014;63:1116\u201335.","journal-title":"Hypertension"},{"key":"6121_CR34","doi-asserted-by":"crossref","unstructured":"Flynn JT, Urbina EM, Brady TM, et al.Atherosclerosis, Hypertension, and Obesity in the Young Committee of the American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular Radiology and Intervention; Council on Epidemiology and Prevention ; Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health. Ambulatory blood pressure monitoring in children and adolescents: 2022 update: a scientific statement from the American Heart Association. Hypertension. 2022;79:e114\u201324.","DOI":"10.1161\/HYP.0000000000000215"},{"key":"6121_CR35","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1161\/HYP.0000000000000228","volume":"80","author":"B Falkner","year":"2023","unstructured":"Falkner B, Gidding SS, Baker-Smith CM, et al; American Heart Association Council on Hypertension; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Kidney in Cardiovascular Disease; Council on Lifestyle and Cardiometabolic Health; and Council on Cardiovascular and Stroke Nursing. Pediatric primary hypertension: an underrecognized condition: a scientific statement from the American Heart Association. Hypertension. 2023;80:e101\u201311.","journal-title":"Hypertension"},{"key":"6121_CR36","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1097\/HJH.0000000000002160","volume":"37","author":"A D\u00fczova","year":"2019","unstructured":"D\u00fczova A, Karabay Bayazit A, et al; 4C Study Consortium. Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease: findings from the Cardiovascular Comorbidity in children with Chronic Kidney Disease study. J Hypertens. 2019;37:2247\u201355.","journal-title":"J Hypertens"},{"key":"6121_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12098-016-2207-y","volume":"84","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Sinha A, Lakshmy R, et al. Ambulatory blood pressure monitoring in frequently relapsing nephrotic syndrome. Indian J Pediatr. 2017;84:31\u20135.","journal-title":"Indian J Pediatr"},{"key":"6121_CR38","doi-asserted-by":"publisher","first-page":"896054","DOI":"10.3389\/fped.2022.896054","volume":"10","author":"H Wu","year":"2022","unstructured":"Wu H, Shi L, Lin Y, Zheng T. The correlation between ABPM parameters and left ventricular hypertrophy in pediatric essential hypertension. Front Pediatr. 2022;10:896054.","journal-title":"Front Pediatr"},{"key":"6121_CR39","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/HYPERTENSIONAHA.122.20190","volume":"80","author":"J Chung","year":"2023","unstructured":"Chung J, Robinson CH, Yu A, et al. Risk of target organ damage in children with primary ambulatory hypertension: a systematic review and meta-analysis. Hypertension. 2023;80:1183\u201396.","journal-title":"Hypertension"},{"key":"6121_CR40","doi-asserted-by":"publisher","first-page":"1088857","DOI":"10.3389\/fped.2023.1088857","volume":"11","author":"M Ahlenius","year":"2023","unstructured":"Ahlenius M, Koek W, Yamaguchi I. Ambulatory blood pressure monitoring in children: A retrospective single-center study. Front Pediatr. 2023;11:1088857.","journal-title":"Front Pediatr"},{"key":"6121_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00467-025-06803-4","volume":"41","author":"CD Hanevold","year":"2026","unstructured":"Hanevold CD, Seo JD, Daniels SR, et al. Ambulatory blood pressure variability in prediction of target organ injury: the SHIP AHOY study. Pediatr Nephrol. 2026;41:157\u201365.","journal-title":"Pediatr Nephrol"},{"key":"6121_CR42","doi-asserted-by":"publisher","first-page":"e2024067463","DOI":"10.1542\/peds.2024-067463","volume":"154","author":"JT Nugent","year":"2024","unstructured":"Nugent JT, Kaelber DC. Utilization of ambulatory blood pressure monitoring in children and adolescents with hypertension. Pediatrics. 2024;154:e2024067463.","journal-title":"Pediatrics"},{"key":"6121_CR43","doi-asserted-by":"publisher","first-page":"114633","DOI":"10.1016\/j.jpeds.2025.114633","volume":"284","author":"V Cueto","year":"2025","unstructured":"Cueto V, Medvecky H, Funaro MC, Nugent JT. Accuracy of home blood pressure monitoring in youth: a systematic review and meta-analysis. J Pediatr. 2025;284:114633.","journal-title":"J Pediatr"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-026-06121-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-026-06121-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-026-06121-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:02:36Z","timestamp":1777363356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-026-06121-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["6121"],"URL":"https:\/\/doi.org\/10.1007\/s12098-026-06121-z","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"24 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}